Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HS-10561 Capsule in Healthy Chinese Adults and Patients With Chronic Spontaneous Urticaria. [Phase 1, Phase 2]

View source ↗

Summary

This is a Phase 1/2 clinical trial evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of HS-10561 capsules in healthy adults and pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Urticaria

Drugs mentioned

• HS-10561 Capsule

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Chronic Spontaneous Urticaria | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING